Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12282PMID 24219059PMCID PMC4093920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute kidney injury during therapy with an antisense oligonucleotide directed against PCSK9.

  2013cited by this paper
• Serum cystatin C as a marker of renal function in detection of early acute kidney injury

  2013cited by this paper
• Mesenchymal stem cell-conditioned medium accelerates regeneration of human renal proximal tubule epithelial cells after gentamicin toxicity.

  2013cited by this paper
• Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

  2013cited by this paper
• Proximal tubular renal dysfunction or damage in HIV-infected patients.

  2012cited by this paper
• Signaling through the interleukin-18 receptor α attenuates inflammation in cisplatin-induced acute kidney injury.

  2012cited by this paper
• Urinary N‐acetyl‐β‐d‐Glucosaminidase Levels are Positively Correlated With 2‐Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes

  2012cited by this paper
• Tissue Kim-1 and Urinary Clusterin as Early Indicators of Cisplatin-Induced Acute Kidney Injury in Rats

  2012cited by this paper
• Detection and management of nephrotoxicity during drug development

  2012cited by this paper
• Nephrotoxicity of hexachloro‐1:3‐butadiene in the male Hanover Wistar rat; correlation of minimal histopathological changes with biomarkers of renal injury

  2012cited by this paper
• Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats.

  2011cited by this paper
• Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.

  2011cited by this paper
• Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury

  2011cited by this paper
• Early detection of renal damage caused by fumaric acid ester therapy by determination of urinary β2‐microglobulin

  2011cited by this paper
• Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study

  2011cited by this paper
• [Measurement of renal function in clinical practice: principles and limitations].

  2011cited by this paper
• The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo vadis.

  2011cited by this paper
• Mesures de la performance rénale en clinique : principes et limites

  2011cited by this paper
• Cystatin C: influence of perfusion and myocardial injury on early (<24 h) renal function after pediatric cardiac surgery

  2011cited by this paper
• Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Multi-site Preclinical Biomarker Qualification Studies

  2010cited by this paper
• Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity.

  2010cited by this paper
• Biomarkers of acute kidney injury: an evolving domain.

  2010cited by this paper
• Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

  2010cited by this paper
• Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury

  2010cited by this paper
• Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats.

  2010cited by this paper
• Kidney Injury Molecule-1 Expression in Rat Proximal Tubule after Treatment with Segment-Specific Nephrotoxicants

  2010cited by this paper
• A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

  2010cited by this paper
• Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.

  2010cited by this paper
• Early biomarkers of cadmium exposure and nephrotoxicity

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters

  2009cited by this paper
• Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity.

  2009cited by this paper
• Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin

  2009cited by this paper
• IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis.

  2009cited by this paper
• Glomerular filtration rate measurement and prediction equations

  2009cited by this paper
• Measured GFR as a confirmatory test for estimated GFR.

  2009cited by this paper
• Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.

  2008cited by this paper
• Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans

  2008cited by this paper
• Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity.

  2007cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy.

  2007cited by this paper
• How to estimate GFR-serum creatinine, serum cystatin C or equations?

  2007cited by this paper
• Tissue Localization of Human Trefoil Factors 1, 2, and 3

  2007cited by this paper
• Systematic Reviews of Animal Experiments Demonstrate Poor Human Clinical and Toxicological Utility

  2007cited by this paper
• Altered expression of trefoil factor 3 and cathepsin L gene in rat kidney during aging

  2007cited by this paper
• How to measure renal function in clinical practice

  2006cited by this paper
• Urinary β 2-Microglobulin as a Possible Sensitive Marker for Renal Injury Caused by Tenofovir Disoproxil Fumarate

  2006cited by this paper
• Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.

  2006cited by this paper
• Assessing kidney function--measured and estimated glomerular filtration rate.

  2006cited by this paper
• Reactions to the chief medical officer's report

  2006cited by this paper
• Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Identification of putative gene based markers of renal toxicity.

  2004cited by this paper
• Urinary interleukin-18 is a marker of human acute tubular necrosis.

  2004cited by this paper
• Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis.

  2004cited by this paper
• INCREASED URINARY EXCRETION OF N-ACETYLGLUCOSAMINIDASE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE

  2002cited by this paper
• Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor

  2000cited by this paper
• Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure

  1999cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• How to assess glomerular function and damage in humans.

  1999cited by this paper
• The predictivity of the toxicity of pharmaceuticals in humans from animal data--an interim assessment.

  1998cited by this paper
• Acute renal failure.

  1996cited by this paper
• Clusterin: physiologic and pathophysiologic considerations.

  1995cited by this paper
• Glutathione transferases in the urine: sensitive methods for detection of kidney damage induced by nephrotoxic agents in humans.

  1994cited by this paper
• Markers predicting progression of human immunodeficiency virus-related disease

  1994cited by this paper
• Expression of clusterin in human renal diseases.

  1994cited by this paper
• Expression and purification of a trefoil peptide motif in a beta-galactosidase fusion protein and its use to search for trefoil-binding sites.

  1993cited by this paper
• Role of β2-Microglobulin in Cytomegalovirus Infection

  1990cited by this paper
• Beta 2-microglobulin: its significance and clinical usefulness.

  1990cited by this paper
• Physiologic adaptations of the tubuloglomerular feedback system.

  1990cited by this paper
• Role of beta 2-microglobulin in cytomegalovirus infection.

  1990cited by this paper
• Urinary Glutathione-S-Transferase in Cisplatin Nephrotoxicity in the Rat

  1986cited by this paper
• Urinary ligandin and glutathione-S-transferase in gentamicin-induced nephrotoxicity in the rat.

  1981cited by this paper
• Ligandinuria in nephrotoxic acute tubular necrosis.

  1977cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Acute Renal Failure

  1960cited by this paper

• Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial.

  2026cites this paper
• Novel Kidney Biomarkers and Antibiotics‐Induced Acute Kidney Injury: A Practical Assessment of Current and Future Applications

  2025cites this paper
• Kidneys on the Frontline: Nephrologists Tackling the Wilds of Acute Kidney Injury in Trauma Patients—From Pathophysiology to Early Biomarkers

  2025cites this paper
• Diagnosis and Emerging Biomarkers of Cystic Fibrosis-Related Kidney Disease (CFKD)

  2025cites this paper
• A Common Adverse Outcome Pathway for Metal(loid)s Inducing Nephrotoxicity to Advance Next-Generation Risk Assessment of Chemical Mixtures.

  2025cites this paper
• Comparative Evaluation of Urinary Biomarkers in Wilms Tumor Survivors and Children with Chronic Kidney Disease

  2025cites this paper
• Fatty acids as potential biomarkers of stearoyl-CoA desaturase inhibition: variation in healthy subjects and Parkinson's disease patients.

  2025cites this paper
• The effects of methamphetamine intoxication on acute kidney injury in Iraqi male addicts

  2025cites this paper
• The α-Helical Amphipathic Peptide Alleviates Colistin-Induced Nephrotoxicity by Maintaining Mitochondrial Function in Both In Vitro and In Vivo Infection Models

  2025cites this paper
• Effects of Zofenopril and Thymoquinone in Cyclophosphamide-Induced Urotoxicity and Nephrotoxicity in Rats; The Value of Their Anti-Inflammatory and Antioxidant Properties

  2025cites this paper
• Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents

  2025cites this paper
• Safety of applying influenza-antigen-coated microneedles to rat skin and the antigen specific immune response in vivo

  2024cites this paper
• A Pharmacokinetic/Toxicodynamic Model of Cisplatin Nephrotoxicity Using the Kidney Injury Molecule-1 Biomarker.

  2024cites this paper
• Contemporary considerations for nephrotoxin stewardship: Estimating kidney function and use of novel biomarkers

  2024cites this paper
• Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies

  2024cites this paper
• Serum Amyloid A3 Promoter-Luciferase Reporter Mice Are Useful for Early Drug-Induced Nephrotoxicity Detection

  2024influential citation
• Agmatine ameliorates diabetes type 2-induced nephropathy in rats

  2024cites this paper
• Assessment of renal function indexes in methamphetamine or tramadol intoxication adults to the emergency departments: a systematic review and meta-analysis

  2023cites this paper
• miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer

  2023cites this paper
• Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage, and regeneration response after cisplatin

  2023cites this paper
• Amino Acids from Urine as Possible Biomarkers for Early Detection of Vancomycin Nephrotoxicity

  2022cites this paper
• Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications

  2022cites this paper
• Evaluation of Novel Urinary Biomarkers in Beagle Dogs With Amphotericin B-Induced Kidney Injury

  2022cites this paper
• Overview of Methotrexate Toxicity: A Comprehensive Literature Review

  2022cites this paper
• Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).

  2022cites this paper
• Evaluation of renal tubulointerstitial damage as a residual renal risk factor for adverse cardiac events in patients with myocardial infarction.

  2021cites this paper
• Serum 5-Hydroxyindoleacetic Acid and Ratio of 5-Hydroxyindoleacetic Acid to Serotonin as Metabolomics Indicators for Acute Oxidative Stress and Inflammation in Vancomycin-Associated Acute Kidney Injury

  2021cites this paper
• The screening of drug-induced nephrotoxicity using gold nanocluster-based ratiometric fluorescent probes.

  2021cites this paper
• Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.

  2021cites this paper
• Role of Renal Transporters in Drug–Drug Interactions and Nephrotoxicity

  2021cites this paper
• Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen

  2021cites this paper
• Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital

  2021cites this paper
• Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review

  2021cites this paper
• Oleic acid exhibits an expressive anti-inflammatory effect in croton oil-induced irritant contact dermatitis without the occurrence of toxicological effects in mice.

  2020cites this paper
• Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective

  2020cites this paper
• Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin

  2020cites this paper
• The effect of melatonin on cisplatin-induced nephrotoxicity: A pilot, randomized, double-blinded, placebo-controlled clinical trial

  2020cites this paper
• Selection of Nontraditional Species for Issue Resolution Studies

  2019cites this paper
• Translational Assessment of Drug‐Induced Proximal Tubule Injury Using a Kidney Microphysiological System

  2019cites this paper
• Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway

  2019cites this paper
• Biomarkers of drug-induced kidney toxicity.

  2019influential citation
• Nephrotoxic Effects of Drugs

  2019cites this paper
• Accentuated Risk of Tenofovir-Associated Nephrotoxicity and Hepatoxicity among HIV Patients in Nigeria: Empirical Evidence from a Cohort Study

  2019cites this paper
• The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity

  2019cites this paper
• Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial

  2018cites this paper
• Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.

  2018cites this paper
• Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury

  2018cites this paper
• Evaluating the Use of KIM‐1 in Drug Development and Research Following FDA Qualification

  2018cites this paper
• Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia.

  2018cites this paper
• Subchronic oral toxicity study of Habb-e-Suranjan in albino Wistar rats

  2018cites this paper
• Innovative lipid-based carriers containing cationic derivatives of polyisoprenoid alcohols augment the antihypertensive effectiveness of candesartan in spontaneously hypertensive rats

  2018cites this paper
• Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult Subjects

  2018cites this paper
• Evaluation of Kidney Injury Molecule-1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) Urinary Levels for Detecting Kidney Dysfunction in Patients With Nasopharyngeal Cancer Treated With Cisplatin-Based Treatment

  2018cites this paper
• Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as early biomarkers for predicting vancomycin-associated acute kidney injury: a prospective study.

  2017cites this paper
• first-in-man studies with novel sglt2 inhibitor: antisense compound is associated with unexpected renal effects

  2017cites this paper
• Comparative toxicity study on classical and modified version of Jawarish Jalinoos (a traditional Unani formulation) in rats

  2017cites this paper
• Novel SGLT2 inhibitor: first‐in‐man studies of antisense compound is associated with unexpected renal effects

  2017cites this paper
• Evaluation of Temporal Changes in Urine-based Metabolomic and Kidney Injury Markers to Detect Compound Induced Acute Kidney Tubular Toxicity in Beagle Dogs.

  2017cites this paper
• Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery

  2016cites this paper
• Effects of Sugammadex and Neostigmine on Renal Biomarkers

  2016cites this paper
• Renal Effects of Antisense-Mediated Inhibition of SGLT2

  2016cites this paper
• A kidney injury molecule‐1 (Kim‐1) gene reporter in a mouse artificial chromosome: the responsiveness to cisplatin toxicity in immortalized mouse kidney S3 cells

  2016cites this paper
• The use of biomarkers in human pharmacology (Phase I) studies.

  2015cites this paper
• Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease

  2015cites this paper
• Drug-induced impairment of renal function

  2014cites this paper
• Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.

  2014cites this paper
• Praktische leidraad voor gebruik van colistine

  2014cites this paper
• Biomarkers of Drug-Induced Kidney Toxicity

  year unknowninfluential citation